| Product Code: ETC11316329 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Suriname import shipments of the whole cell cholera vaccine recombinant B subunit saw significant growth in 2024, with top exporting countries including the United States, Trinidad and Tobago, Brazil, and Netherlands. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. The compound annual growth rate (CAGR) from 2020 to 2024 was impressive at 23.24%, and the growth rate from 2023 to 2024 surged to 81.21%. This data suggests a robust demand for the cholera vaccine in Suriname and a strong market presence of the product in the country.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, 2022 & 2032F |
3.3 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market - Industry Life Cycle |
3.4 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market - Porter's Five Forces |
3.5 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.6 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume Share, By Packaging Type, 2022 & 2032F |
3.7 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
3.8 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Trends |
6 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market, By Types |
6.1 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Product Type, 2022 - 2032F |
6.1.3 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Oral Vaccines, 2022 - 2032F |
6.1.4 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Injectable Vaccines, 2022 - 2032F |
6.1.5 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Combination Vaccines, 2022 - 2032F |
6.2 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market, By Packaging Type |
6.2.1 Overview and Analysis |
6.2.2 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Vials, 2022 - 2032F |
6.2.3 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Ampoules, 2022 - 2032F |
6.2.4 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Pre-filled Syringes, 2022 - 2032F |
6.3 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.3.3 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Specialty Pharmacies, 2022 - 2032F |
6.3.4 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Online Pharmacies, 2022 - 2032F |
6.4 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Healthcare Facilities, 2022 - 2032F |
6.4.3 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Government Immunization Programs, 2022 - 2032F |
6.4.4 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Research Institutions, 2022 - 2032F |
7 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Import-Export Trade Statistics |
7.1 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Export to Major Countries |
7.2 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Imports from Major Countries |
8 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Key Performance Indicators |
9 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market - Opportunity Assessment |
9.1 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.2 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Opportunity Assessment, By Packaging Type, 2022 & 2032F |
9.3 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
9.4 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market - Competitive Landscape |
10.1 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenue Share, By Companies, 2025 |
10.2 Suriname Whole Cell Cholera Vaccine Recombinant B Subunit Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here